Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma

Hideki Nakasone, Yoshinobu Kanda, Tomoki Ueda, Kenji Matsumoto, Naomi Shimizu, Jiro Minami, Rika Sakai, Maki Hagihara, Akira Yokota, Kumi Oshima, Yuiko Tsukada, Takayoshi Tachibana, Chiaki Nakaseko, Shin Fujisawa, Shingo Yano, Hiroyuki Fujita, Satoshi Takahashi, Heiwa Kanamori, Shinichiro Okamoto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The combination of cyclophosphamide and granulocyte-colony stimulating factor (G-CSF) has widely been used to mobilize hematopoietic stem cells (HSCs) for autologous stem cell transplantation (ASCT) for multiple myeloma (MM). Recently, however, alternative approaches such as G-CSF alone or etoposide followed by G-CSF have been investigated. We, therefore, retrospectively analyzed the effects of these mobilization methods on collection yield and disease outcome in ASCT for MM. We reviewed 146 MM patients from whom we intended to collect stem cells. For mobilization, 67, 58, and 21 patients received cyclophosphamide and G-CSF, etoposide and G-CSF, and G-CSF alone (including nonmyelosuppressive chemotherapy followed by G-CSF), respectively. Among them, 136 achieved the target number of HSCs (at least 2 x 106/ kg). Lower creatinine and higher albumin levels at diagnosis were significantly associated with successful yield. A lower number of infused HSCs, use of the etoposide for mobilization and high ISS were associated with delayed hematopoietic recovery. The mobilization methods did not significantly affect either the successful collection of more than 2 x 106 CD34-positive cells/kg or PFS after ASCT. G-CSF alone was sufficient for stem cell mobilization for a single ASCT. The optimal approach to collect HSCs in MM remains to be elucidated.

Original languageEnglish
Pages (from-to)809-814
Number of pages6
JournalAmerican Journal of Hematology
Volume84
Issue number12
DOIs
Publication statusPublished - 2009 Dec

Fingerprint

Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Hematopoietic Stem Cells
Etoposide
Cyclophosphamide
Hematopoietic Stem Cell Mobilization
Albumins
Creatinine
Stem Cells
Drug Therapy

ASJC Scopus subject areas

  • Hematology

Cite this

Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma. / Nakasone, Hideki; Kanda, Yoshinobu; Ueda, Tomoki; Matsumoto, Kenji; Shimizu, Naomi; Minami, Jiro; Sakai, Rika; Hagihara, Maki; Yokota, Akira; Oshima, Kumi; Tsukada, Yuiko; Tachibana, Takayoshi; Nakaseko, Chiaki; Fujisawa, Shin; Yano, Shingo; Fujita, Hiroyuki; Takahashi, Satoshi; Kanamori, Heiwa; Okamoto, Shinichiro.

In: American Journal of Hematology, Vol. 84, No. 12, 12.2009, p. 809-814.

Research output: Contribution to journalArticle

Nakasone, H, Kanda, Y, Ueda, T, Matsumoto, K, Shimizu, N, Minami, J, Sakai, R, Hagihara, M, Yokota, A, Oshima, K, Tsukada, Y, Tachibana, T, Nakaseko, C, Fujisawa, S, Yano, S, Fujita, H, Takahashi, S, Kanamori, H & Okamoto, S 2009, 'Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma', American Journal of Hematology, vol. 84, no. 12, pp. 809-814. https://doi.org/10.1002/ajh.21552
Nakasone, Hideki ; Kanda, Yoshinobu ; Ueda, Tomoki ; Matsumoto, Kenji ; Shimizu, Naomi ; Minami, Jiro ; Sakai, Rika ; Hagihara, Maki ; Yokota, Akira ; Oshima, Kumi ; Tsukada, Yuiko ; Tachibana, Takayoshi ; Nakaseko, Chiaki ; Fujisawa, Shin ; Yano, Shingo ; Fujita, Hiroyuki ; Takahashi, Satoshi ; Kanamori, Heiwa ; Okamoto, Shinichiro. / Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma. In: American Journal of Hematology. 2009 ; Vol. 84, No. 12. pp. 809-814.
@article{08a9f703f931425884d3739637b101a2,
title = "Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma",
abstract = "The combination of cyclophosphamide and granulocyte-colony stimulating factor (G-CSF) has widely been used to mobilize hematopoietic stem cells (HSCs) for autologous stem cell transplantation (ASCT) for multiple myeloma (MM). Recently, however, alternative approaches such as G-CSF alone or etoposide followed by G-CSF have been investigated. We, therefore, retrospectively analyzed the effects of these mobilization methods on collection yield and disease outcome in ASCT for MM. We reviewed 146 MM patients from whom we intended to collect stem cells. For mobilization, 67, 58, and 21 patients received cyclophosphamide and G-CSF, etoposide and G-CSF, and G-CSF alone (including nonmyelosuppressive chemotherapy followed by G-CSF), respectively. Among them, 136 achieved the target number of HSCs (at least 2 x 106/ kg). Lower creatinine and higher albumin levels at diagnosis were significantly associated with successful yield. A lower number of infused HSCs, use of the etoposide for mobilization and high ISS were associated with delayed hematopoietic recovery. The mobilization methods did not significantly affect either the successful collection of more than 2 x 106 CD34-positive cells/kg or PFS after ASCT. G-CSF alone was sufficient for stem cell mobilization for a single ASCT. The optimal approach to collect HSCs in MM remains to be elucidated.",
author = "Hideki Nakasone and Yoshinobu Kanda and Tomoki Ueda and Kenji Matsumoto and Naomi Shimizu and Jiro Minami and Rika Sakai and Maki Hagihara and Akira Yokota and Kumi Oshima and Yuiko Tsukada and Takayoshi Tachibana and Chiaki Nakaseko and Shin Fujisawa and Shingo Yano and Hiroyuki Fujita and Satoshi Takahashi and Heiwa Kanamori and Shinichiro Okamoto",
year = "2009",
month = "12",
doi = "10.1002/ajh.21552",
language = "English",
volume = "84",
pages = "809--814",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma

AU - Nakasone, Hideki

AU - Kanda, Yoshinobu

AU - Ueda, Tomoki

AU - Matsumoto, Kenji

AU - Shimizu, Naomi

AU - Minami, Jiro

AU - Sakai, Rika

AU - Hagihara, Maki

AU - Yokota, Akira

AU - Oshima, Kumi

AU - Tsukada, Yuiko

AU - Tachibana, Takayoshi

AU - Nakaseko, Chiaki

AU - Fujisawa, Shin

AU - Yano, Shingo

AU - Fujita, Hiroyuki

AU - Takahashi, Satoshi

AU - Kanamori, Heiwa

AU - Okamoto, Shinichiro

PY - 2009/12

Y1 - 2009/12

N2 - The combination of cyclophosphamide and granulocyte-colony stimulating factor (G-CSF) has widely been used to mobilize hematopoietic stem cells (HSCs) for autologous stem cell transplantation (ASCT) for multiple myeloma (MM). Recently, however, alternative approaches such as G-CSF alone or etoposide followed by G-CSF have been investigated. We, therefore, retrospectively analyzed the effects of these mobilization methods on collection yield and disease outcome in ASCT for MM. We reviewed 146 MM patients from whom we intended to collect stem cells. For mobilization, 67, 58, and 21 patients received cyclophosphamide and G-CSF, etoposide and G-CSF, and G-CSF alone (including nonmyelosuppressive chemotherapy followed by G-CSF), respectively. Among them, 136 achieved the target number of HSCs (at least 2 x 106/ kg). Lower creatinine and higher albumin levels at diagnosis were significantly associated with successful yield. A lower number of infused HSCs, use of the etoposide for mobilization and high ISS were associated with delayed hematopoietic recovery. The mobilization methods did not significantly affect either the successful collection of more than 2 x 106 CD34-positive cells/kg or PFS after ASCT. G-CSF alone was sufficient for stem cell mobilization for a single ASCT. The optimal approach to collect HSCs in MM remains to be elucidated.

AB - The combination of cyclophosphamide and granulocyte-colony stimulating factor (G-CSF) has widely been used to mobilize hematopoietic stem cells (HSCs) for autologous stem cell transplantation (ASCT) for multiple myeloma (MM). Recently, however, alternative approaches such as G-CSF alone or etoposide followed by G-CSF have been investigated. We, therefore, retrospectively analyzed the effects of these mobilization methods on collection yield and disease outcome in ASCT for MM. We reviewed 146 MM patients from whom we intended to collect stem cells. For mobilization, 67, 58, and 21 patients received cyclophosphamide and G-CSF, etoposide and G-CSF, and G-CSF alone (including nonmyelosuppressive chemotherapy followed by G-CSF), respectively. Among them, 136 achieved the target number of HSCs (at least 2 x 106/ kg). Lower creatinine and higher albumin levels at diagnosis were significantly associated with successful yield. A lower number of infused HSCs, use of the etoposide for mobilization and high ISS were associated with delayed hematopoietic recovery. The mobilization methods did not significantly affect either the successful collection of more than 2 x 106 CD34-positive cells/kg or PFS after ASCT. G-CSF alone was sufficient for stem cell mobilization for a single ASCT. The optimal approach to collect HSCs in MM remains to be elucidated.

UR - http://www.scopus.com/inward/record.url?scp=73349134627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73349134627&partnerID=8YFLogxK

U2 - 10.1002/ajh.21552

DO - 10.1002/ajh.21552

M3 - Article

C2 - 19862826

AN - SCOPUS:73349134627

VL - 84

SP - 809

EP - 814

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 12

ER -